Testing focused radiation with and without an extra edge for cancer that spread to the brain
Original title: Frameless Stereotactic Radiosurgery for Intact Brain Metastases
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a mid-stage test in people, so it is not regular care yet.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a tighter radiation target works as well for tumors that spread to the brain.
Who this trial is for. This trial is for people with cancer that has spread to the brain from somewhere else in the body. It tests focused radiation given without a head frame, and whether skipping a small extra edge of radiation around each tumor lets the tumors grow back sooner.
Where it stands. People are put into groups by chance. The team is looking at how long people go before their tumors grow again. This trial has not reported results yet.
What this means, and what it doesn't
What it could mean: This trial asks a careful question about how to aim radiation at brain tumors. If you have cancer that spread to the brain, you might ask your care team if this trial could fit you.
What it doesn't mean: A trial is a test, not a proven treatment. Taking part does not promise that you will be helped. It is not a cure. It does not show yet that one way of giving radiation is better than the other.
Source: ClinicalTrials.gov, September 14, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.